"This is the first trial that's shown that you can add immunotherapy to chemotherapy and show improved response and a survival benefit," said Meeks.
"For more than 20 years, the standard of care for advanced bladder cancer involved chemotherapy followed by radical cystectomy, or surgical removal of the bladder and surrounding lymph nodes."
"These patients have the most to lose or gain, so that's why we treat them more aggressively. What hasn't been clear is if adding immunotherapy to chemotherapy has any benefit."
"The findings demonstrate the potential of a new treatment regimen for patients with locally advanced bladder cancer, according to Joshua Meeks."
[
Collection
]
[
|
...
]